Joseph P Lyssikatos $ELVN SEC Form 4 Insider Trading

Joseph P Lyssikatos has filed a total of 36 insider trades in $ELVN since 2021. Their most recent trade was a sale of 4,670 shares, made on Apr 21, 2025. Their largest trade was a sale of 34,289 shares, made on Oct 09, 2024. We estimate that they now own 1.0 million shares of $ELVN, worth an estimated $18.7 million.

Insider Trading at $ELVN

There have been a total of 186 insider trades reported at $ELVN since 2021, with 621 shares purchased and 4.4 million shares sold. The most active insider traders in $ELVN stock have been Benjamin Hohl, Joseph P Lyssikatos, and Samuel Kintz. The most recent trade was a sale of 4,670 shares reported by Joseph P Lyssikatos (CHIEF SCIENTIFIC OFFICER), made on Apr 21, 2025.

$ELVN Executives and Stock Owners with Insider Trades

• Benjamin Hohl, CHIEF FINANCIAL OFFICER

• Joseph P Lyssikatos, CHIEF SCIENTIFIC OFFICER

• Samuel Kintz, PRESIDENT AND CEO

• Anish Patel, CHIEF OPERATING OFFICER

• Joseph P Lyssikatos, Chief Scientific Officer

• Samuel Kintz, President and CEO

• Anish Patel, Chief Operating Officer

• Benjamin Hohl, Chief Financial Officer

• Helen Louise Collins, CHIEF MEDICAL OFFICER

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.